1. Home
  2. NBTX vs DSP Comparison

NBTX vs DSP Comparison

Compare NBTX & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTX
  • DSP
  • Stock Information
  • Founded
  • NBTX 2003
  • DSP 1999
  • Country
  • NBTX France
  • DSP United States
  • Employees
  • NBTX N/A
  • DSP N/A
  • Industry
  • NBTX Biotechnology: Pharmaceutical Preparations
  • DSP EDP Services
  • Sector
  • NBTX Health Care
  • DSP Technology
  • Exchange
  • NBTX Nasdaq
  • DSP Nasdaq
  • Market Cap
  • NBTX 211.9M
  • DSP 220.3M
  • IPO Year
  • NBTX 2020
  • DSP 2021
  • Fundamental
  • Price
  • NBTX $9.85
  • DSP $9.87
  • Analyst Decision
  • NBTX Strong Buy
  • DSP Strong Buy
  • Analyst Count
  • NBTX 1
  • DSP 8
  • Target Price
  • NBTX $8.00
  • DSP $21.13
  • AVG Volume (30 Days)
  • NBTX 15.0K
  • DSP 364.9K
  • Earning Date
  • NBTX 09-17-2025
  • DSP 08-11-2025
  • Dividend Yield
  • NBTX N/A
  • DSP N/A
  • EPS Growth
  • NBTX N/A
  • DSP N/A
  • EPS
  • NBTX N/A
  • DSP 0.13
  • Revenue
  • NBTX N/A
  • DSP $318,471,000.00
  • Revenue This Year
  • NBTX N/A
  • DSP $16.28
  • Revenue Next Year
  • NBTX $74.67
  • DSP $15.43
  • P/E Ratio
  • NBTX N/A
  • DSP $74.17
  • Revenue Growth
  • NBTX N/A
  • DSP 30.92
  • 52 Week Low
  • NBTX $2.76
  • DSP $9.07
  • 52 Week High
  • NBTX $10.59
  • DSP $26.33
  • Technical
  • Relative Strength Index (RSI)
  • NBTX 75.73
  • DSP 35.68
  • Support Level
  • NBTX $8.20
  • DSP $9.07
  • Resistance Level
  • NBTX $10.59
  • DSP $13.83
  • Average True Range (ATR)
  • NBTX 0.51
  • DSP 0.66
  • MACD
  • NBTX 0.18
  • DSP -0.13
  • Stochastic Oscillator
  • NBTX 79.95
  • DSP 16.82

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About DSP Viant Technology Inc.

Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.

Share on Social Networks: